[Thyroid tissue link of hemostasis in diffuse toxic and euthyroid goiter]

Area of Science:

• Endocrinology and Hematology
• Investigating the intricate interplay between thyroid function and hemostasis.

Context:

• Thyroid gland tissue harbors factors crucial for blood coagulation and fibrinolysis.
• Previous research has not fully elucidated the specific hemostatic profiles within thyroid tissues of goiter patients.

Purpose:

• To investigate and compare the blood coagulation and fibrinolysis factors within the thyroid gland tissue of patients with diffuse toxic goiter, euthyroid goiter, and healthy individuals.
• To understand the alterations in local hemostasis associated with different goiter conditions.

Summary:

• Healthy thyroid tissue exhibits thromboplastin, antithrombin, anticoagulant, antiheparin, plasminogen, plasminogen activators, and antiplasmins.
• In diffuse toxic goiter, reduced thromboplastin and antiheparin activity, alongside increased aggregation and disaggregation, impair the external coagulation system.
• Both diffuse toxic and euthyroid goiter patients exhibit enhanced local fibrinolysis due to increased plasminogen activators, reduced antiplasmin activity, and heightened nonenzymatic fibrinolysis.

Impact:

• Findings reveal significant alterations in thyroidal hemostasis in goiter patients, suggesting a potential role in disease pathogenesis.
• Highlights the distinct hemostatic profiles in euthyroid versus diffuse toxic goiter.
• Provides a basis for further research into the clinical implications of these hemostatic changes in thyroid disorders.